Presenting data at a prestigious conference like AACR can significantly boost a company's profile in the scientific and investment communities. For Kazia Therapeutics, this exposure is likely to attract positive attention to their research and development efforts, potentially leading to increased investor confidence and a positive impact on stock price in the short term.